InVivo Therapeutics Conference Call
CAMBRIDGE, Mass. (September 2, 2011) – InVivo Therapeutics Holdings Corp. (OTC/BB: NVIV), a company focused on the development of groundbreaking technologies for the treatment of spinal cord injuries (SCI), today announced that the company will hold a conference call on September 8th at 11:00 a.m. Eastern time during which Frank Reynolds, Chief Executive Officer, will provide a business update.
To participate in the conference call from the U.S. please dial 1-877-941-2068; from outside the U.S. please dial 1-480-629-9712. All listeners should reference the InVivo Therapeutics business update conference call and provide conference I.D. 4470404. Individuals interested in listening to the conference call [live] via the Internet may do so by following the below link.